FOX04-DRI

FOXO4-DRI (FOXO4–D-Retro-Inverso peptide) is a synthetic peptide designed for use in laboratory research exploring cellular senescence, apoptosis signaling, and longevity-related pathways. It is engineered to interfere with the interaction between FOXO4 and p53, a key pathway involved in the regulation of cell survival and programmed cell death.

In preclinical research models, FOXO4-DRI has been studied for its potential to influence senescent cell signaling, where aged or damaged cells exhibit altered function. Researchers are particularly interested in how modulation of this pathway may impact cellular clearance mechanisms and tissue homeostasis in controlled environments.

Due to its targeted mechanism, FOXO4-DRI is commonly examined in research areas including:

FOXO4-DRI continues to be a compound of interest in aging research and senescence-focused studies, where scientists aim to better understand the role of senescent cells in biological systems.

Product Information

* Product Name: FOXO4-DRI

* Category: Longevity / Senolytic Research Peptide

* Purity: ≥99% High-purity research grade

* Use: Laboratory research and analytical studies

Important Research Notice

This product is intended for laboratory research purposes only.

FOXO4-DRI is not approved by the FDA for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease. All products offered by Genora Peptides are supplied strictly for in-vitro laboratory research conducted by qualified professionals.

⚠️ For Research Purposes Only: This product is intended for laboratory research use only. Not for human or animal consumption.